Fulcrum Therapeutics (FULC) Assets (2019 - 2025)
Historic Assets for Fulcrum Therapeutics (FULC) over the last 7 years, with Q3 2025 value amounting to $214.9 million.
- Fulcrum Therapeutics' Assets fell 2299.22% to $214.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $214.9 million, marking a year-over-year decrease of 2299.22%. This contributed to the annual value of $260.7 million for FY2024, which is 117.35% up from last year.
- Per Fulcrum Therapeutics' latest filing, its Assets stood at $214.9 million for Q3 2025, which was down 2299.22% from $228.8 million recorded in Q2 2025.
- Fulcrum Therapeutics' Assets' 5-year high stood at $321.1 million during Q1 2023, with a 5-year trough of $137.9 million in Q2 2021.
- Its 5-year average for Assets is $241.4 million, with a median of $242.6 million in 2025.
- Per our database at Business Quant, Fulcrum Therapeutics' Assets surged by 8135.93% in 2021 and then plummeted by 2756.98% in 2024.
- Quarter analysis of 5 years shows Fulcrum Therapeutics' Assets stood at $235.0 million in 2021, then dropped by 3.54% to $226.7 million in 2022, then grew by 13.68% to $257.7 million in 2023, then grew by 1.17% to $260.7 million in 2024, then fell by 17.59% to $214.9 million in 2025.
- Its last three reported values are $214.9 million in Q3 2025, $228.8 million for Q2 2025, and $242.6 million during Q1 2025.